Skip to Content
Merck
All Photos(1)

Key Documents

15525

Sigma-Aldrich

Boc-Tyr-OSu

≥99.0% (N)

Synonym(s):

Boc-L-tyrosine hydroxysuccinimide ester

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C18H22N2O7
CAS Number:
Molecular Weight:
378.38
Beilstein:
1557147
MDL number:
UNSPSC Code:
12352200
PubChem Substance ID:

Assay

≥99.0% (N)

optical activity

[α]20/D −13±1°, c = 1% in dioxane

mp

~190 °C (dec.)

application(s)

peptide synthesis

storage temp.

−20°C

SMILES string

CC(C)(C)OC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)ON2C(=O)CCC2=O

InChI

1S/C18H22N2O7/c1-18(2,3)26-17(25)19-13(10-11-4-6-12(21)7-5-11)16(24)27-20-14(22)8-9-15(20)23/h4-7,13,21H,8-10H2,1-3H3,(H,19,25)/t13-/m0/s1

InChI key

NZUDTLHVKHXJJJ-ZDUSSCGKSA-N

Other Notes

Reagent used in a rapid method for iodotyrosylation of peptides.; This method is equal to that of Bolton-Hunter but has the additional advantage that the derivatized peptide is readily deblocked to form a radiolabelled product with the same net charge as the starting material

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Iodotyrosylation of peptides using tertiary-Butyloxycarbonyl-L-[125I]iodotyrosine N-hydroxysuccinimide ester.
R K Assoian et al.
Analytical biochemistry, 103(1), 70-76 (1980-03-15)
Patrick Neuberg et al.
International journal of pharmaceutics, 566, 141-148 (2019-05-28)
Small interfering RNAs (siRNAs) can down-regulate the expression of a target mRNA molecule in a sequence-specific manner, making them an attractive new class of drugs with broad potential for the treatment of diverse human diseases. Here, we report the synthesis

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service